Citigroup’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.7M | Buy |
125,348
+72,543
| +137% | +$12.7M | 0.01% | 975 |
|
|
2025
Q4 | $8.98M | Sell |
52,805
-134,301
| -72% | -$20.6M | ﹤0.01% | 1619 |
|
|
2025
Q3 | $24.7M | Buy |
187,106
+10,114
| +6% | +$1.21M | 0.01% | 952 |
|
|
2025
Q2 | $18.8M | Buy |
176,992
+3,998
| +2% | +$434K | 0.01% | 998 |
|
|
2025
Q1 | $21.5M | Buy |
172,994
+135,309
| +359% | +$17.7M | 0.01% | 934 |
|
|
2024
Q4 | $4.64M | Sell |
37,685
-5,118
| -12% | -$603K | ﹤0.01% | 2040 |
|
|
2024
Q3 | $4.77M | Buy |
42,803
+20,767
| +94% | +$2.28M | ﹤0.01% | 1889 |
|
|
2024
Q2 | $2.35M | Sell |
22,036
-44,098
| -67% | -$4.85M | ﹤0.01% | 2211 |
|
|
2024
Q1 | $7.96M | Sell |
66,134
-2,925
| -4% | -$358K | 0.01% | 1395 |
|
|
2023
Q4 | $8.49M | Buy |
69,059
+12,238
| +22% | +$1.53M | 0.01% | 1304 |
|
|
2023
Q3 | $7.35M | Sell |
56,821
-5,826
| -9% | -$776K | 0.01% | 1253 |
|
|
2023
Q2 | $7.77M | Sell |
62,647
-30,301
| -33% | -$4.08M | 0.01% | 1247 |
|
|
2023
Q1 | $13.6M | Sell |
92,948
-3,928
| -4% | -$581K | 0.01% | 999 |
|
|
2022
Q4 | $15.4M | Sell |
96,876
-12,750
| -12% | -$1.87M | 0.01% | 914 |
|
|
2022
Q3 | $14.6M | Buy |
109,626
+66,272
| +153% | +$10.1M | 0.01% | 951 |
|
|
2022
Q2 | $6.76M | Sell |
43,354
-2,513
| -5% | -$387K | 0.01% | 1351 |
|
|
2022
Q1 | $7.14M | Buy |
45,867
+1,180
| +3% | +$171K | ﹤0.01% | 1477 |
|
|
2021
Q4 | $5.69M | Sell |
44,687
-31,037
| -41% | -$4.08M | ﹤0.01% | 1731 |
|
|
2021
Q3 | $9.86M | Sell |
75,724
-22,089
| -23% | -$3.34M | 0.01% | 1423 |
|
|
2021
Q2 | $17.4M | Sell |
97,813
-52,028
| -35% | -$9.01M | 0.01% | 1077 |
|
|
2021
Q1 | $24.6M | Buy |
149,841
+43,387
| +41% | +$7.14M | 0.02% | 840 |
|
|
2020
Q4 | $17.6M | Buy |
106,454
+47,721
| +81% | +$7.11M | 0.01% | 1128 |
|
|
2020
Q3 | $8.38M | Sell |
58,733
-22,985
| -28% | -$2.85M | 0.01% | 1511 |
|
|
2020
Q2 | $9.02M | Buy |
81,718
+10,238
| +14% | +$1.13M | 0.01% | 1381 |
|
|
2020
Q1 | $7.13M | Sell |
71,480
-1,121
| -2% | -$145K | 0.01% | 1396 |
|
|
2019
Q4 | $10.8M | Buy |
72,601
+2,497
| +4% | +$340K | 0.01% | 1429 |
|
|
2019
Q3 | $8.98M | Sell |
70,104
-16,199
| -19% | -$2.17M | 0.01% | 1474 |
|
|
2019
Q2 | $12.3M | Buy |
86,303
+38,480
| +80% | +$5.17M | 0.01% | 1253 |
|
|
2019
Q1 | $6.84M | Sell |
47,823
-48,104
| -50% | -$6.27M | 0.01% | 1546 |
|
|
2018
Q4 | $11.9M | Buy |
95,927
+52,866
| +123% | +$7.84M | 0.01% | 1142 |
|
|
2018
Q3 | $7.24M | Buy |
43,061
+3,203
| +8% | +$551K | 0.01% | 1522 |
|
|
2018
Q2 | $6.87M | Buy |
39,858
+25,065
| +169% | +$4.1M | 0.01% | 1565 |
|
|
2018
Q1 | $2.23M | Sell |
14,793
-2,609
| -15% | -$383K | ﹤0.01% | 2507 |
|
|
2017
Q4 | $2.34M | Sell |
17,402
-23,432
| -57% | -$3.25M | ﹤0.01% | 2515 |
|
|
2017
Q3 | $5.97M | Buy |
40,834
+23,646
| +138% | +$3.58M | ﹤0.01% | 1593 |
|
|
2017
Q2 | $2.67M | Buy |
17,188
+2,436
| +17% | +$373K | ﹤0.01% | 2283 |
|
|
2017
Q1 | $2.14M | Buy |
14,752
+10,443
| +242% | +$1.36M | ﹤0.01% | 2415 |
|
|
2016
Q4 | $470K | Sell |
4,309
-14,993
| -78% | -$1.67M | ﹤0.01% | 4435 |
|
|
2016
Q3 | $2.35M | Buy |
19,302
+7,811
| +68% | +$1.05M | ﹤0.01% | 2364 |
|
|
2016
Q2 | $1.62M | Sell |
11,491
-4,134
| -26% | -$609K | ﹤0.01% | 2502 |
|
|
2016
Q1 | $2.04M | Buy |
15,625
+1,582
| +11% | +$197K | ﹤0.01% | 2461 |
|
|
2015
Q4 | $1.97M | Buy |
14,043
+8,434
| +150% | +$1.17M | ﹤0.01% | 2496 |
|
|
2015
Q3 | $745K | Sell |
5,609
-17,307
| -76% | -$2.98M | ﹤0.01% | 3361 |
|
|
2015
Q2 | $4.04M | Sell |
22,916
-15,756
| -41% | -$2.83M | ﹤0.01% | 1926 |
|
|
2015
Q1 | $6.68M | Buy |
38,672
+12,641
| +49% | +$2.17M | 0.01% | 1500 |
|
|
2014
Q4 | $4.26M | Sell |
26,031
-113,484
| -81% | -$18.8M | ﹤0.01% | 1909 |
|
|
2014
Q3 | $22.4M | Buy |
139,515
+78,708
| +129% | +$12.1M | 0.02% | 731 |
|
|
2014
Q2 | $8.94M | Buy |
60,807
+41,265
| +211% | +$5.72M | 0.01% | 1338 |
|
|
2014
Q1 | $2.71M | Sell |
19,542
-682
| -3% | -$103K | ﹤0.01% | 2154 |
|
|
2013
Q4 | $2.56M | Buy |
20,224
+6,801
| +51% | +$704K | ﹤0.01% | 2355 |
|
|
2013
Q3 | $1.24M | Buy |
13,423
+11,455
| +582% | +$924K | ﹤0.01% | 2756 |
|
|
2013
Q2 | $136K | Buy |
+1,968
| New | +$120K | ﹤0.01% | 4589 |
|
Other funds holding JAZZ
VPM
VCM
EC
Citigroup's JAZZ Position: Q1 2026 in Review
Citigroup increased its Jazz Pharmaceuticals (JAZZ) stake by 137% in Q1 2026, buying an estimated $12.7M and bringing the position to 125,348 shares worth $23.7M. The position accounts for 0.01% of the portfolio, ranked #975.
Citigroup first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.7M in Q3 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Citigroup held 125,348 shares of Jazz Pharmaceuticals worth $23.7M as of Q1 2026.
- Citigroup bought 72,543 Jazz Pharmaceuticals shares in Q1 2026, an estimated $12.7M.
- Jazz Pharmaceuticals made up 0.01% of Citigroup's portfolio in Q1 2026, its #975 holding.
- Citigroup first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Jazz Pharmaceuticals position peaked at $24.7M in Q3 2025.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.